11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature

Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances

(2012) Paolo Galuppo et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Aldosterone-Induced Fibrosis in the Kidney: Questions and Controversies

(2011) Andrew S. Brem et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Toll-like receptors and macrophage activation in atherosclerosis

(2011) Anusha N. Seneviratne et al.   CLINICA CHIMICA ACTA

STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease

(2011) Krzysztof Sikorski et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Novel Fat Depot-Specific Mechanisms Underlie Resistance to Visceral Obesity and Inflammation in 11 -Hydroxysteroid Dehydrogenase Type 1-Deficient Mice

(2011) M. Wamil et al.   DIABETES

11β-Hydroxysteroid Dehydrogenase Type 1, But Not Type 2, Deficiency Worsens Acute Inflammation and Experimental Arthritis in Mice

(2011) Agnes E. Coutinho et al.   ENDOCRINOLOGY

Tissue-specific modulation of mineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases: An overview

(2011) Alex Odermatt et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Mineralocorticoid receptors in vascular function and disease

(2011) Amy McCurley et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The Hemostatic System as a Modulator of Atherosclerosis

(2011) Julian Ilcheff Borissoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Activation of Mineralocorticoid Receptors by Exogenous Glucocorticoids and the Development of Cardiovascular Inflammatory Responses in Adrenalectomized Rats

(2010) Morag J. Young et al.   ENDOCRINOLOGY

11β-Hydroxysteroid Dehydrogenase Type 2 Deficiency Accelerates Atherogenesis and Causes Proinflammatory Changes in the Endothelium inApoe−/−Mice

(2010) Graeme A. Deuchar et al.   ENDOCRINOLOGY

Identification and validation of genes affecting aortic lesions in mice

(2010) Xia Yang et al.   JOURNAL OF CLINICAL INVESTIGATION

The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights

(2010) Agnes E. Coutinho et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Aldosterone and Mineralocorticoid Receptors in the Cardiovascular System

(2010) John W. Funder   PROGRESS IN CARDIOVASCULAR DISEASES

Immune and Inflammatory Mechanisms of Atherosclerosis

(2009) Elena Galkina et al.   Annual Review of Immunology

Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure

(2009) Amanda J. Rickard et al.   HYPERTENSION

Hypercoagulable State in Cushing’s Syndrome: A Systematic Review

(2009) Bregje Van Zaane et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses

(2009) J Hoppmann et al.   JOURNAL OF ENDOCRINOLOGY

Inflammation in Atherosclerosis

(2009) Peter Libby et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Functional Mineralocorticoid Receptors in Human Vascular Endothelial Cells Regulate Intercellular Adhesion Molecule-1 Expression and Promote Leukocyte Adhesion

(2008) Massimiliano Caprio et al.   CIRCULATION RESEARCH

Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart

(2008) Peter Wilson et al.   CLINICAL SCIENCE

Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation

(2008) Morag J Young   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION